Eduardo Daniel Anica-Malagón
Research Subjects
Eduardo Daniel Anica-Malagón has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Alberto Ignacio Álvarez López
2 shared publications- Berenice Zavala Barrios
Secretaría de Salud (SSa). Hospital General de México “Dr. Eduardo Liceaga”. Diagnóstico y Tratamiento. Ciudad de México, México
2 shared publications Carlos Gabriel Briones Vega
2 shared publicationsEnrique Gómez Bravo Topete
2 shared publicationsHospital General de México Dr. Eduardo Liceaga Ginecología Y Obstetricia
2 shared publicationsHospital General de México Dr. Eduardo Liceaga Medicina Materno Fetal
2 shared publications
Latest Publications
- Open Access
- 13 July 2026
- Vol. 64 (4) , e6961
[When the one who heals dies. The physician at the end of life].
A physician's death represents a critical point of tension between the values of modern medicine and the ethical limits of care. This review article analyzes how physicians face their own end of life and the type of care they receive compared with the general population. A narrative review of literature published between 2014 and 2025 was conducted using PubMed, Scopus, and SciELO databases with the MeSH and DeCS descriptors: "Terminal care", "Palliative care", "Attitude to death", "Health personnel", "Right to die". Findings show that although physicians express a preference for a dignified death with therapeutic proportionality and symptom control, many still die under highly technological and interventionist schemes. Mexico lacks systematic data documenting how its physicians die, revealing a gap between ethical intention and institutional practice. This analysis proposes developing a observational study to characterize therapeutic intensity, respect for autonomy, and the moral distress experienced by healthcare teams as bioethical and occupational issues within the health system.
- 13 July 2026
- Vol. 64 (4) , e6961
Open Access[When the one who heals dies. The physician at the end of life].
A physician's death represents a critical point of tension between the values of modern medicine and the ethical limits of care. This review article analyzes how physicians face their own end of life and the type of care they receive compared with the general population. A narrative review of literature published between 2014 and 2025 was conducted using PubMed, Scopus, and SciELO databases with the MeSH and DeCS descriptors: "Terminal care", "Palliative care", "Attitude to death", "Health personnel", "Right to die". Findings show that although physicians express a preference for a dignified death with therapeutic proportionality and symptom control, many still die under highly technological and interventionist schemes. Mexico lacks systematic data documenting how its physicians die, revealing a gap between ethical intention and institutional practice. This analysis proposes developing a observational study to characterize therapeutic intensity, respect for autonomy, and the moral distress experienced by healthcare teams as bioethical and occupational issues within the health system.
- Open Access
- 13 July 2026
- Vol. 64 (4) , e6998
[Thinking, evaluating, and replenishing the fibrinogen hemostatic strategy in neurosurgery].
Hemostatic control in neurosurgery represents a major clinical challenge, in which even small variations in blood loss can critically alter intracranial pressure and neurological prognosis. Fibrinogen, the first coagulation factor to be depleted during hemorrhage, is also an early marker of coagulopathy and a key determinant of clot stability. This narrative review analyzed the scientific literature published between 2020 and 2025 in PubMed, Scopus, and the Cochrane Library, with emphasis on studies evaluating the pathophysiology, diagnosis, and targeted replacement of fibrinogen in neurosurgical patients. Through critical analysis and systematic integration of the selected studies, convergent evidence was identified demonstrating that low fibrinogen levels are associated with greater blood loss, an increased risk of intracranial rebleeding, and poorer functional outcomes. Viscoelastic test-guided administration allows dose optimization and reduction of transfusion requirements, while empirical strategies based on serum concentrations and surgical context provide safe alternatives when such technologies are unavailable. Understanding when and how to replace fibrinogen constitutes an essential component of comprehensive patient blood management in neurosurgery. This paradigm, summarized by the principle "think, assess, and replace", consolidates an integrated model of goal-directed neurohemostasis.
- 13 July 2026
- Vol. 64 (4) , e6998
Open Access[Thinking, evaluating, and replenishing the fibrinogen hemostatic strategy in neurosurgery].
Hemostatic control in neurosurgery represents a major clinical challenge, in which even small variations in blood loss can critically alter intracranial pressure and neurological prognosis. Fibrinogen, the first coagulation factor to be depleted during hemorrhage, is also an early marker of coagulopathy and a key determinant of clot stability. This narrative review analyzed the scientific literature published between 2020 and 2025 in PubMed, Scopus, and the Cochrane Library, with emphasis on studies evaluating the pathophysiology, diagnosis, and targeted replacement of fibrinogen in neurosurgical patients. Through critical analysis and systematic integration of the selected studies, convergent evidence was identified demonstrating that low fibrinogen levels are associated with greater blood loss, an increased risk of intracranial rebleeding, and poorer functional outcomes. Viscoelastic test-guided administration allows dose optimization and reduction of transfusion requirements, while empirical strategies based on serum concentrations and surgical context provide safe alternatives when such technologies are unavailable. Understanding when and how to replace fibrinogen constitutes an essential component of comprehensive patient blood management in neurosurgery. This paradigm, summarized by the principle "think, assess, and replace", consolidates an integrated model of goal-directed neurohemostasis.
- Open Access
- 3 November 2025
- Vol. 63 (6) , e6721
[Advance Directives in Geriatrics: Proposed Management Algorithm].
This work encompasses both a review article and the proposal of an operational model for the implementation of advance directives in older adults with terminal or end-stage illnesses within the Geriatrics Department, conceived as an ethical and clinical strategy aimed at promoting autonomy at the end of life. Through a comprehensive regulatory, bioethical, and epidemiological review, as well as an analysis of institutional barriers, we developed an algorithm that includes candidate identification, provision of information to patients and their families, obtaining informed consent, formalization of the document, registration, and ongoing follow-up. The methodology was grounded in the integration of national and international evidence, the clinical experience of the team, and current Mexican legislation. Our proposal seeks to foster shared anticipatory decision-making, reduce futile interventions, and humanize the dying process. We conclude that the institutionalization of clear protocols regarding advance directives enhances the quality of palliative care, facilitates proactive planning, decreases family conflicts, and strengthens respect for the dignity of older adults.
- 3 November 2025
- Vol. 63 (6) , e6721
Open Access[Advance Directives in Geriatrics: Proposed Management Algorithm].
This work encompasses both a review article and the proposal of an operational model for the implementation of advance directives in older adults with terminal or end-stage illnesses within the Geriatrics Department, conceived as an ethical and clinical strategy aimed at promoting autonomy at the end of life. Through a comprehensive regulatory, bioethical, and epidemiological review, as well as an analysis of institutional barriers, we developed an algorithm that includes candidate identification, provision of information to patients and their families, obtaining informed consent, formalization of the document, registration, and ongoing follow-up. The methodology was grounded in the integration of national and international evidence, the clinical experience of the team, and current Mexican legislation. Our proposal seeks to foster shared anticipatory decision-making, reduce futile interventions, and humanize the dying process. We conclude that the institutionalization of clear protocols regarding advance directives enhances the quality of palliative care, facilitates proactive planning, decreases family conflicts, and strengthens respect for the dignity of older adults.
- 1 January 2019
- Published by Universidad Nacional Autonoma de Mexico
Medicina crítica en Obstetricia Tomo II
- 1 January 2019
- Published by Universidad Nacional Autonoma de Mexico
Medicina crítica en Obstetricia Tomo II
- 1 January 2018
- Published by Universidad Nacional Autonoma de Mexico
Medicina crítica en Obstetricia Tomo I
- 1 January 2018
- Published by Universidad Nacional Autonoma de Mexico
Medicina crítica en Obstetricia Tomo I